Hamlet BioPharma AB Logo

Hamlet BioPharma AB

HAMLET | SPGR

Overview

Corporate Details

ISIN(s):
SE0015661145 (+2 more)
LEI:
549300HJV2LJY4CDBR64
Country:
Sweden
Address:
Klinikgatan 32, 222 42 LUND
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hamlet BioPharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nippon Shinyaku Co.,Ltd. Logo Nippon Shinyaku Co.,Ltd. Japan 4516
Noile-Immune Biotech Inc. Logo Noile-Immune Biotech Inc. Japan 4893
Novartis AG Logo Novartis AG Switzerland NOVN
Nur Ink Innovations Ltd. Logo Nur Ink Innovations Ltd. Israel NURI
Nxera Pharma Co., Ltd. Logo Nxera Pharma Co., Ltd. Japan 4565
ObsEva SA Logo ObsEva SA Switzerland OBSN
ODI Pharma AB Logo ODI Pharma AB Sweden ODI
Oncolys BioPharma Inc. Logo Oncolys BioPharma Inc. Japan 4588
OncoTherapy Science, Inc. Logo OncoTherapy Science, Inc. Japan 4564
OncoZenge AB Logo OncoZenge AB Sweden ONCOZ